Intelligence / Healthtech / New Clinical Trials / SkylineDx
Clinicaltrial registered13 Nov 2026
SkylineDx
13 Nov 2026: Trial registered · Prospective, Multi-Center Observational Registry of Melanoma CP-GEP and Clinical Outcomes. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 13 Nov 2026
- Title
- Prospective, Multi-Center Observational Registry of Melanoma CP-GEP and Clinical Outcomes
- Conditions
- Melanoma (Skin Cancer), Gene Expression Profiling
- Study Type
- Observational
- Status
- Not Yet Recruiting
- Reference
- NCT07934550
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at SkylineDx
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.